Who founded BioNTech?

BioNTech was founded by Ozlem Tureci, Ugur Sahin.

Who are BioNTech's investors?

BioNTech's investors include Manta Ray Ventures, MIG Capital AG, Onsight Ventures, Pfizer Venture Investments.

How much funding has BioNTech raised?

BioNTech has disclosed $400M raised across 2 rounds.

Where is BioNTech headquartered?

BioNTech is headquartered in Mainz.

BioNTech

Mainz · 4 known investors

Find your way into BioNTech

107 people in our graph share verified history with the BioNTech team — schools, employers, funds. One of them is your warm intro.

Andrea Gazviniunlockedknows Ugur Sahin · together at University of Cologne

×11knows the team · via University of Cologne

BioNTech is a biotechnology company developing immunotherapies that use the body's immune system, combining multiple therapeutic modalities and biological targets to treat cancer, infectious diseases, and other serious conditions. It operates globally in the pharmaceutical and biotech industry.

Biotech Healthtech

Founders & leadership

Ozlem TureciCo-founder

Ugur Sahin inCo-founderFounder and CEO of BioNTech, Ugur Sahin is a medical doctor with a background in scientific research and a focus on translating research into therapeutic applications across oncology and infectious disease.

Sierk PoettinginExecutive

Sean MarettinExecutive

Ryan RichardsoninExecutive

Board

Christoph HuberBoard director

Michael Motschmann inBoard directorManaging Partner at MIG Capital AG

Helmut JeggleBoard director

Ulrich WandschneiderBoard director

Investors · 4

Manta Ray VenturesLondon

MIG Capital AGMunich · $1.1M – $10.8M

Onsight VenturesInnsbruck · $216K – $2.2M

Pfizer Venture Investments$5M – $20M

Reported raises · per SEC filings

Form D private placements

$400M disclosed across 2 rounds · 2020–2022

▶$150MraisedApr 2022 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Ryan RichardsonExecutive Officer
Ugur SahinExecutive Officer
Michael MotschmannDirector
Sierk PoettingExecutive Officer
Christoph HuberDirector
Jens HolsteinExecutive Officer
Ozlem TureciExecutive Officer
Ulrich WandschneiderDirector
Sean MarettExecutive Officer
Helmut JeggleDirector

Offering amount: $150M
Amount sold: $150M
First sale: Apr 2022
Incorporated: Corporation, Germany
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$250MraisedSep 2020 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Sierk PoettingExecutive Officer
Sean MarettExecutive Officer
Ulrich WandschneiderDirector
Christoph HuberDirector
Ozlem TureciExecutive Officer
Michael MotschmannDirector
Ugur SahinExecutive Officer
Helmut JeggleDirector
Ryan RichardsonExecutive Officer

Offering amount: $250M
Amount sold: $250M
First sale: Sep 2020
Incorporated: Corporation, Germany
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does BioNTech do?: BioNTech is a biotechnology company developing immunotherapies that use the body's immune system, combining multiple therapeutic modalities and biological targets to treat cancer, infectious diseases, and other serious conditions. It operates globally in the pharmaceutical and biotech industry.
Who founded BioNTech?: BioNTech was founded by Ozlem Tureci, Ugur Sahin.
Who are BioNTech's investors?: BioNTech's investors include Manta Ray Ventures, MIG Capital AG, Onsight Ventures, Pfizer Venture Investments.
How much funding has BioNTech raised?: BioNTech has disclosed $400M raised across 2 rounds.
Where is BioNTech headquartered?: BioNTech is headquartered in Mainz.